CG Oncology (CGON) Cash from Operations (2023 - 2026)

CG Oncology (CGON) has 4 years of Cash from Operations data on file, last reported at 56900000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 94.35% year-over-year to 56900000.0; the trailing twelve-month figure through Mar 2026 stood at 159969000.0 (down 95.14% YoY), and the FY2025 full-year result was 132346000.0, down 68.14% from the prior year.
• Cash from Operations for Q1 2026 stood at 56900000.0, down from 36246000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 7986000.0 in Q1 2023 and bottomed at 56900000.0 in Q1 2026.
• The 4-year median for Cash from Operations is 20662000.0 (2024), against an average of 24126000.0.
• The widest annual swing landed in 2024, when Cash from Operations slumped 225.72%; it then retreated 12.55% in 2025.
• A 4-year view of Cash from Operations shows it stood at 14645000.0 in 2023, then tumbled by 41.09% to 20662000.0 in 2024, then slumped by 75.42% to 36246000.0 in 2025, then plunged by 56.98% to 56900000.0 in 2026.
• The last three Cash from Operations figures came in at 56900000.0 (Q1 2026), 36246000.0 (Q4 2025), and 38900000.0 (Q3 2025), per Business Quant data.

Peer Comparison